Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
292 JPY | +0.69% | +10.19% | +2.46% |
13/02 | Stella Pharma Corporation Provides Earnings Guidance for the Fiscal Year Ending March 2024 | CI |
2023 | Stella Pharma Corporation Provides Earnings Guidance for the Fiscal Year Ending March 2024 | CI |
Sales 2022 | 100 15.61K 8.34K | Sales 2023 | 229 35.74K 19.11K | Capitalization | 11.49B 1,792B 958B |
---|---|---|---|---|---|
Net income 2022 | -767M -120B -64B | Net income 2023 | -778M -121B -64.92B | EV / Sales 2022 | 15,25,84,976 x |
Net cash position 2022 | 2.02B 316B 169B | Net cash position 2023 | 1.62B 252B 135B | EV / Sales 2023 | 4,30,92,444 x |
P/E ratio 2022 |
-22.1
x | P/E ratio 2023 |
-14.4
x | Employees | 46 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 50.76% |
1 day | +0.69% | ||
1 week | +10.19% | ||
Current month | +0.34% | ||
1 month | +1.74% | ||
3 months | +9.77% | ||
6 months | +5.42% | ||
Current year | +2.46% |
Managers | Title | Age | Since |
---|---|---|---|
Tomoyuki Asano
CHM | Chairman | 53 | 01/07/01 |
Koki Uehara
PSD | President | 46 | 01/07/01 |
Director/Board Member | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Kazumitsu Yabu
BRD | Director/Board Member | 65 | 01/15/01 |
Kiyoshi Nagata
BRD | Director/Board Member | 69 | 01/17/01 |
Masaya Onishi
BRD | Director/Board Member | 49 | 01/16/01 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 292 | +0.69% | 43,700 |
25/24/25 | 290 | -1.36% | 71,200 |
24/24/24 | 294 | +5.00% | 84,200 |
23/24/23 | 280 | +1.08% | 41,900 |
22/24/22 | 277 | +4.53% | 93,600 |
Delayed Quote Japan Exchange, April 26, 2024 at 11:30 am IST
More quotes1st Jan change | Capi. | |
---|---|---|
+2.46% | 57.92M | |
+26.47% | 661B | |
+26.74% | 566B | |
-6.33% | 352B | |
+19.35% | 332B | |
+4.23% | 283B | |
+13.43% | 231B | |
+4.71% | 200B | |
-9.53% | 195B | |
-4.04% | 145B |
- Stock Market
- Equities
- 4888 Stock